APOE rs12720838: Understanding This Regulatory Variant
The rs12720838 variant is a genetic change located in the regulatory region of the APOE gene. It is associated with the modulation of circulating apolipoprotein levels and how the body processes dietary fats.
What each genotype means
Typical regulatory profile
This genotype represents the most common regulatory configuration for the APOE gene region in many populations. Research into this specific variant is limited, but it is generally considered the baseline against which other variations are measured regarding APOE transcription and lipid modulation. As with all genetic findings, this does not determine your health outcomes, and you should discuss any concerns about lipid levels or cardiovascular health with your healthcare provider.
Carried by the majority of individuals in most populations, consistent with the reported minor allele frequency of approximately 0.18 for the T allele.
Varied regulatory profile
Carrying one copy of the T allele at this position may influence the upstream regulation of the APOE gene, potentially affecting how the body modulates circulating apolipoprotein levels in response to dietary fats. Current evidence regarding the clinical significance of this specific variant is limited, and it is not a primary driver of lipid disorders compared to well-known APOE coding variants. Please consult with a clinician or registered dietitian if you are managing specific lipid or cardiovascular health goals.
Carried by roughly 1 in 3 people of European ancestry, based on a minor allele frequency of approximately 0.18.
Alternative regulatory profile
This genotype represents the homozygous state for the less common allele at this regulatory site. While this variant is associated with the modulation of APOE transcription and lipid responses to dietary fats, the overall impact on clinical health remains limited and requires further study. This result should not be used to predict specific health outcomes, and any questions regarding your lipid profile should be addressed through standard clinical screening with your doctor.
Carried by approximately 3% to 4% of individuals of European ancestry, based on a minor allele frequency of approximately 0.18.
What is rs12720838?
The rs12720838 variant is a single nucleotide polymorphism (SNP) situated in the upstream regulatory region of the APOE gene. In genetics, regulatory regions are segments of DNA that act as control switches, determining when and how much of a specific protein is produced by a gene. Because this variant is located outside of the protein-coding sequence, it does not change the structure of the APOE protein itself. Instead, it is thought to influence the transcription process, which is the first step in turning genetic instructions into functional proteins. By altering the efficiency or timing of this process, rs12720838 may lead to variations in the amount of apolipoprotein E circulating in the bloodstream. Researchers study such variants to understand how subtle differences in gene regulation contribute to individual differences in metabolic health and lipid profiles.
The Role of the APOE Gene
The APOE gene provides instructions for making apolipoprotein E, a protein that plays a critical role in the metabolism of fats in the body. This protein combines with fats to form lipoproteins, which are particles that package cholesterol and triglycerides so they can travel through the bloodstream. Apolipoprotein E is essential for the normal breakdown of these fat-rich particles, helping to clear them from the blood and deliver them to cells that need them for energy or structural repair. Because of its central role in lipid transport, the APOE gene is a major focus of cardiovascular and neurological research. Variations in this gene can affect how efficiently the body manages cholesterol levels, which in turn influences overall metabolic health. Understanding how regulatory variants like rs12720838 affect this gene helps scientists map the complex relationship between genetics, diet, and lipid homeostasis.
Research Associations and Evidence
Current research into rs12720838 suggests it plays a role in modulating plasma lipid levels, particularly in response to dietary fat intake. While the APOE gene is well-known for its association with lipid metabolism and cognitive health, the specific evidence for rs12720838 is currently categorized as limited. Studies have observed that this variant may influence how an individual's lipid profile responds to different dietary patterns, such as the consumption of saturated fats or cholesterol. However, it is important to note that these associations are statistical in nature and do not imply a direct cause-and-effect relationship for every individual. Much of the existing data comes from genome-wide association studies (GWAS), which look for correlations across large populations. Because the evidence is limited, scientists continue to investigate whether this variant acts independently or in conjunction with other genetic factors to influence long-term health outcomes.
Population Frequency
The rs12720838 variant is found across various human populations, though its frequency varies. In European populations, the minor allele frequency is approximately 0.18, meaning it is relatively common but not the most frequent version of the DNA sequence at this location. Genetic diversity means that the prevalence of this variant can differ significantly when comparing individuals of different ancestral backgrounds. These frequency differences are a standard feature of human genetics and are tracked by large-scale projects like gnomAD to help researchers understand the distribution of genetic traits globally. Knowing the frequency of a variant helps scientists determine if an observed association is consistent across different groups or if it is specific to certain populations.
Interpreting Your Genetic Information
If you have information about your genotype for rs12720838, it is important to view it within the context of your overall health. Genetic variants are only one piece of a much larger puzzle that includes diet, lifestyle, environment, and other genetic factors. Because the evidence for this specific variant is limited, it cannot be used to predict specific health outcomes or to provide personalized medical advice. You should never use genetic data to make changes to your diet or medication regimen without consulting a qualified healthcare professional. If you are concerned about your lipid levels or cardiovascular health, speak with your doctor or a registered dietitian. They can provide guidance based on your clinical history and standard blood tests, which are far more reliable indicators of your current health status than any single genetic variant.
How common is this variant?
The minor allele frequency for rs12720838 is approximately 0.18 in European populations, indicating that the variant is present in a significant portion of the population.
Frequently asked questions
Is rs12720838 a diagnostic test for heart disease?
No, rs12720838 is not a diagnostic test. It is a genetic variant studied in research settings to understand biological pathways, and it cannot predict whether an individual will develop heart disease.
Can I change my diet based on my rs12720838 genotype?
You should not make dietary changes based on this variant. Always consult with a doctor or a registered dietitian who can evaluate your overall health and blood lipid levels before recommending any dietary adjustments.
What does it mean if a variant has 'limited' evidence?
Limited evidence means that while some studies have shown a statistical association, the findings are not yet robust or consistent enough to be used for clinical decision-making. More research is needed to confirm the role of the variant.
Where can I find more information about the APOE gene?
You can find reliable information about the APOE gene and its functions on the MedlinePlus Genetics website, which provides educational summaries for the general public.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12720838?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in APOE
Variant in the APOE/TOMM40 locus associated with late-onset Alzheimer's disease risk.
Downstream variant in the APOE region associated with lipid metabolism profiles and healthspan indicators.
Variant (c.497G>A, p.Arg166Gln) in the APOE gene known as Apolipoprotein E4 Christchurch, which has been shown in clinical case studies to confer resistance to familial Alzheimer's disease pathology.
Defines the APOE ε2 allele, associated with lower LDL cholesterol and reduced risk of Alzheimer's disease.
Regulatory variant in the APOE promoter region modulating transcriptional activity and risk for late-onset neurodegeneration.
Variant in the APOE gene cluster strongly associated with low-density lipoprotein cholesterol levels and altered susceptibility to cardiovascular disease.